NEWS
Helsenæringens verdi 2020
Helsenæringen er en dobbel mulighet for Norge.
Norwegian cancer drug in COVID 19-programme
Bemcentinib from the Norwegian biotech BerGenBio will be tested on COVID-19 patients.
Artificial intelligence in the fight against COVID-19
Adapting cancer-fighting artificial intelligence technology to combat COVID-19.
Accelerating cell therapies against cancer
Oslo Cancer Cluster Incubator will develop the infrastructure for cancer cell therapies.
Programming to understand artificial intelligence
How can programming, artificial intelligence and machine learning help us to better understand the human brain?
New member: Glaxo Smith Kline
Find out how Glaxo Smith Kline (GSK), the latest pharmaceutical cluster to enter into our ecosystem, is contributing to the oncology field.
Our funding support: up to €60 000 per SME
Our funding support: up to €60 000 per SME
Funding opportunities for health and IT SMEs
DIGI-B-CUBE Open Call - Innovation vouchers to support the SMEs
New member: Vesteraalens
Find out why a company specialising in seafood and marine ingredients has become a member of an oncology cluster.